EMBECTA CORP. Increase (Decrease) in Accrued Taxes Payable
EMBECTA CORP. (EMBC) reported Increase (Decrease) in Accrued Taxes Payable of -$3.60 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedTaxesPayable · last filed 2026-08-07
- EMBECTA CORP. increase (decrease) in accrued taxes payable for the quarter ending 2026-06-30 was $900.00K, a 90.91% decline year-over-year.
- EMBECTA CORP. increase (decrease) in accrued taxes payable for the quarter ending 2026-03-31 was -$2.70M.
- EMBECTA CORP. increase (decrease) in accrued taxes payable for the quarter ending 2025-12-31 was -$1.80M.
- EMBECTA CORP. increase (decrease) in accrued taxes payable for the quarter ending 2025-09-30 was -$11.20M, a 286.67% decline year-over-year.
- EMBECTA CORP. increase (decrease) in accrued taxes payable for fiscal 2025 was -$28.10M, a 312.88% decline from fiscal 2024.
- EMBECTA CORP. increase (decrease) in accrued taxes payable for fiscal 2024 was $13.20M.
- EMBECTA CORP. increase (decrease) in accrued taxes payable for fiscal 2023 was -$12.60M, a 222.33% decline from fiscal 2022.
- EMBECTA CORP. increase (decrease) in accrued taxes payable for fiscal 2022 was $10.30M.
| Period end | Increase (Decrease) in Accrued Taxes Payable 3 month | Increase (Decrease) in Accrued Taxes Payable 6 month | Increase (Decrease) in Accrued Taxes Payable 9 month | Increase (Decrease) in Accrued Taxes Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | -$1.80M derived: sum of 2 quarters · filed 2026-08-07 | -$3.60M 10-Q · filed 2026-08-07 | -$14.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | -$4.50M 10-Q · filed 2026-05-05 | -$15.70M derived: sum of 3 quarters · filed 2026-05-05 | -$5.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$1.80M 10-Q · filed 2026-02-05 | -$13.00M derived: sum of 2 quarters · filed 2026-02-05 | -$3.10M derived: sum of 3 quarters · filed 2026-08-07 | -$3.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | -$11.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$1.30M derived: sum of 2 quarters · filed 2026-08-07 | -$1.80M derived: sum of 3 quarters · filed 2026-08-07 | -$28.10M 10-K · filed 2025-11-25 |
| 2025-06-30 | $9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $9.40M derived: sum of 2 quarters · filed 2026-08-07 | -$16.90M 10-Q · filed 2026-08-07 | -$10.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | -$26.80M 10-Q · filed 2026-05-05 | -$20.80M derived: sum of 3 quarters · filed 2026-05-05 | -$6.60M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$26.30M 10-Q · filed 2026-02-05 | -$20.30M derived: sum of 2 quarters · filed 2026-02-05 | -$6.10M derived: sum of 3 quarters · filed 2026-02-05 | -$17.50M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-09-30 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $20.20M derived: sum of 2 quarters · filed 2025-11-25 | $8.80M derived: sum of 3 quarters · filed 2025-11-25 | $13.20M 10-K · filed 2025-11-25 |
| 2024-06-30 | $14.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $2.80M derived: sum of 2 quarters · filed 2025-08-08 | $7.20M 10-Q · filed 2025-08-08 | -$16.70M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | -$11.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-09 | -$7.00M 10-Q · filed 2025-05-09 | -$30.90M derived: sum of 3 quarters · filed 2025-11-25 | -$30.20M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | $4.40M 10-Q · filed 2025-02-06 | -$19.50M derived: sum of 2 quarters · filed 2025-11-25 | -$18.80M derived: sum of 3 quarters · filed 2025-11-25 | -$26.40M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | -$23.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$23.20M derived: sum of 2 quarters · filed 2025-11-25 | -$30.80M derived: sum of 3 quarters · filed 2025-11-25 | -$12.60M 10-K · filed 2025-11-25 |
| 2023-06-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | -$6.90M derived: sum of 2 quarters · filed 2024-08-09 | $11.30M 10-Q · filed 2024-08-09 | $10.80M derived: sum of 4 quarters · filed 2024-12-11 |
| 2023-03-31 | -$7.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $10.60M 10-Q · filed 2024-05-09 | $10.10M derived: sum of 3 quarters · filed 2024-12-11 | $11.20M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-12-31 | $18.20M 10-Q · filed 2024-02-09 | $17.70M derived: sum of 2 quarters · filed 2024-12-11 | $18.80M derived: sum of 3 quarters · filed 2024-12-11 | $28.50M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-09-30 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | $600.00K derived: sum of 2 quarters · filed 2024-12-11 | $10.30M derived: sum of 3 quarters · filed 2024-12-11 | $10.30M 10-K · filed 2024-12-11 |
| 2022-06-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $10.80M derived: sum of 2 quarters · filed 2023-08-08 | $10.80M 10-Q · filed 2023-08-08 | $10.80M derived: sum of 4 quarters · filed 2023-11-29 |
| 2022-03-31 | $9.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $9.70M 10-Q · filed 2023-05-12 | $9.70M derived: sum of 3 quarters · filed 2023-11-29 | |
| 2021-12-31 | $0.00 10-Q · filed 2023-02-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-29 | ||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | $0.00 10-K · filed 2023-11-29 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 | |||
| 2020-09-30 | $0.00 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |